mdxhealth
Brent Weiser is a seasoned professional in the molecular diagnostics and sales sectors, currently serving as a Molecular Diagnostic Specialist at MDxHealth since May 2021. Prior experience includes roles as a Sales Consultant at Biodesix, Inc. from November 2020 to May 2021, and as a Pulmonary Product Specialist and Veracyte Product Specialist at Veracyte, Inc. between January 2018 and November 2020. Brent's career began at Prometheus Laboratories Inc., a Nestlé Health Science Company, where positions included District Sales Manager and Senior Technical Sales Specialist from December 2010 to December 2017. Brent holds a Bachelor of Science degree in Biology from Texas Tech University, completed between 2001 and 2004.
This person is not in any offices
mdxhealth
Mdxhealth is a multinational healthcare company that provides actionable molecular diagnostic information to personalize the diagnosis and treatment of cancer. The company's tests are based on proprietary genetic, epigenetic (methylation) and other molecular technologies and assist physicians with the diagnosis of urologic cancers, prognosis of recurrence risk, and prediction of response to a specific therapy. The Company's European headquarters are in Herstal, Belgium, with laboratory operations in Nijmegen, The Netherlands, and US headquarters and laboratory operations based in Irvine, California.